146 related articles for article (PubMed ID: 38105593)
1. Direct Comparison of the Hinge-Cleaving Proteases IgdE and BdpK for LC-MS-Based IgG1 Clonal Profiling.
van Rijswijck DMH; Bondt A; de Kat N; Lood R; Heck AJR
Anal Chem; 2024 Jan; 96(1):23-27. PubMed ID: 38105593
[TBL] [Abstract][Full Text] [Related]
2. Protein-Centric Analysis of Personalized Antibody Repertoires Using LC-MS-Based Fab-Profiling on a timsTOF.
Fiala J; Schuster D; Ollivier S; Pengelley S; Lubeck M; Busch F; Jankevics A; Raether O; Greisch JF; Heck AJR
J Am Soc Mass Spectrom; 2024 Jun; 35(6):1292-1300. PubMed ID: 38662593
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry.
Xu J; Coughlin JE; Szyjka M; Jabary S; Saluja S; Sosic Z; Chen Y; Xu CF
MAbs; 2024; 16(1):2334783. PubMed ID: 38536719
[TBL] [Abstract][Full Text] [Related]
4. Novel IgG-Degrading Enzymes of the IgdE Protease Family Link Substrate Specificity to Host Tropism of Streptococcus Species.
Spoerry C; Hessle P; Lewis MJ; Paton L; Woof JM; von Pawel-Rammingen U
PLoS One; 2016; 11(10):e0164809. PubMed ID: 27749921
[TBL] [Abstract][Full Text] [Related]
5. The lysosomal endopeptidases Cathepsin D and L are selective and effective proteases for the middle-down characterization of antibodies.
Čaval T; Hecht ES; Tang W; Uy-Gomez M; Nichols A; Kil YJ; Sandoval W; Bern M; Heck AJR
FEBS J; 2021 Sep; 288(18):5389-5405. PubMed ID: 33713388
[TBL] [Abstract][Full Text] [Related]
6. The Proteolytic Cleavage of Therapeutic Monoclonal Antibody Hinge Region: More Than a Matter of Subclass.
Deveuve Q; Lajoie L; Barrault B; Thibault G
Front Immunol; 2020; 11():168. PubMed ID: 32117299
[TBL] [Abstract][Full Text] [Related]
7. Middle-up analysis of monoclonal antibodies after combined IgdE and IdeS hinge proteolysis: Investigation of free sulfhydryls.
Faid V; Leblanc Y; Bihoreau N; Chevreux G
J Pharm Biomed Anal; 2018 Feb; 149():541-546. PubMed ID: 29179100
[TBL] [Abstract][Full Text] [Related]
8. GingisKHAN™ protease cleavage allows a high-throughput antibody to Fab conversion enabling direct functional assessment during lead identification of human monoclonal and bispecific IgG1 antibodies.
Moelleken J; Endesfelder M; Gassner C; Lingke S; Tomaschek S; Tyshchuk O; Lorenz S; Reiff U; Mølhøj M
MAbs; 2017 Oct; 9(7):1076-1087. PubMed ID: 28805498
[TBL] [Abstract][Full Text] [Related]
9. Identification of cysteinylation of a free cysteine in the Fab region of a recombinant monoclonal IgG1 antibody using Lys-C limited proteolysis coupled with LC/MS analysis.
Gadgil HS; Bondarenko PV; Pipes GD; Dillon TM; Banks D; Abel J; Kleemann GR; Treuheit MJ
Anal Biochem; 2006 Aug; 355(2):165-74. PubMed ID: 16828048
[TBL] [Abstract][Full Text] [Related]
10. Evading pre-existing anti-hinge antibody binding by hinge engineering.
Kim HS; Kim I; Zheng L; Vernes JM; Meng YG; Spiess C
MAbs; 2016; 8(8):1536-1547. PubMed ID: 27606571
[TBL] [Abstract][Full Text] [Related]
11. Cleavage of immunoglobulin G (IgG) and IgA around the hinge region by proteases from Serratia marcescens.
Molla A; Kagimoto T; Maeda H
Infect Immun; 1988 Apr; 56(4):916-20. PubMed ID: 3126147
[TBL] [Abstract][Full Text] [Related]
12. Proton nuclear magnetic resonance studies of human immunoglobulins: conformation of the hinge region of the IgG1 immunoglobulin.
Arata Y; Honzawa M; Shimizu A
Biochemistry; 1980 Oct; 19(22):5130-5. PubMed ID: 6257277
[TBL] [Abstract][Full Text] [Related]
13. Human anti-IgG1 hinge autoantibodies reconstitute the effector functions of proteolytically inactivated IgGs.
Brezski RJ; Luongo JL; Petrone D; Ryan MH; Zhong D; Tam SH; Schmidt AP; Kruszynski M; Whitaker BP; Knight DM; Jordan RE
J Immunol; 2008 Sep; 181(5):3183-92. PubMed ID: 18713989
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
[TBL] [Abstract][Full Text] [Related]
15. IgG anti-hinge antibodies against IgG4 F(ab')
Ota T; Ota SI; Uchino A; Nagano S
Arthritis Res Ther; 2020 Jun; 22(1):161. PubMed ID: 32586370
[TBL] [Abstract][Full Text] [Related]
16. Cleavage of protein A-binding IgA1 with IgA1 protease from Streptococcus sanguis.
Biewenga J; Daus F
Immunol Commun; 1983 Oct; 12(5):491-500. PubMed ID: 6358000
[TBL] [Abstract][Full Text] [Related]
17. Demonstration by pulsed neutron scattering that the arrangement of the Fab and Fc fragments in the overall structures of bovine IgG1 and IgG2 in solution is similar.
Mayans MO; Coadwell WJ; Beale D; Symons DB; Perkins SJ
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):283-91. PubMed ID: 7575466
[TBL] [Abstract][Full Text] [Related]
18. Fragmentation of human IgG by a new protease isolated from the basidiomycete Armillaria mellea.
Hunneyball IM; Stanworth DR
Immunology; 1975 Nov; 29(5):921-31. PubMed ID: 1201861
[TBL] [Abstract][Full Text] [Related]
19. Anti-Hinge Antibodies Recognize IgG Subclass- and Protease-Restricted Neoepitopes.
Falkenburg WJ; van Schaardenburg D; Ooijevaar-de Heer P; Tsang-A-Sjoe MW; Bultink IE; Voskuyl AE; Bentlage AE; Vidarsson G; Wolbink G; Rispens T
J Immunol; 2017 Jan; 198(1):82-93. PubMed ID: 27864476
[TBL] [Abstract][Full Text] [Related]
20. The in vitro resistance of IgG2 to proteolytic attack concurs with a comparative paucity of autoantibodies against peptide analogs of the IgG2 hinge.
Brezski RJ; Oberholtzer A; Strake B; Jordan RE
MAbs; 2011; 3(6):558-67. PubMed ID: 22123056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
